Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development and manufacturing of niche generic and branded pharmaceuticals, particularly in the areas of controlled substances and complex formulations. With a focus on innovative drug delivery systems, Elite Pharmaceuticals offers unique products that cater to unmet medical needs, setting them apart in a competitive market. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and a robust pipeline of products in various stages of development. Recognised for its commitment to quality and compliance, Elite Pharmaceuticals continues to strengthen its market position, contributing to the advancement of healthcare solutions both domestically and internationally.
DitchCarbon Score
How does Elite Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elite Pharmaceuticals, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elite Pharmaceuticals, Inc.'s reported carbon emissions
Elite Pharmaceuticals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is important to note that the company may still be in the early stages of developing its climate strategy. In the broader pharmaceutical industry context, many companies are increasingly focusing on sustainability and setting science-based targets to reduce their carbon footprints. However, without specific commitments or data from Elite Pharmaceuticals, it is unclear how they align with these industry trends. Overall, the absence of emissions data and climate commitments highlights an opportunity for Elite Pharmaceuticals to enhance its environmental strategy and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elite Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
